Cargando…
Rifapentine-Proliposomes for Inhalation: In Vitro and In Vivo Toxicity
BACKGROUND: Oral therapy for pulmonary tuberculosis (TB) treatment suffers from the limitation of hepatic metabolism leading insufficient concentration of antitubercular (anti-TB) drugs in alveolar macrophage which harbors Mycobacterium tuberculosis (MTB). Targeted aerosol delivery of antituberculou...
Autores principales: | Patil-Gadhe, Arpana A., Kyadarkunte, Abhay Y., Pereira, Michael, Jejurikar, Gauri, Patole, Milind S., Risbud, Arun, Pokharkar, Varsha B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413410/ https://www.ncbi.nlm.nih.gov/pubmed/25948966 http://dx.doi.org/10.4103/0971-6580.155361 |
Ejemplares similares
-
Isoniazid Proliposome Powders for Inhalation—Preparation, Characterization and Cell Culture Studies
por: Rojanarat, Wipaporn, et al.
Publicado: (2011) -
Formulation Development and in vitro Characterization of Proliposomes for Topical Delivery of Aceclofenac
por: Gupta, Vandana, et al.
Publicado: (2008) -
Levofloxacin-Proliposomes: Opportunities for Use in Lung Tuberculosis
por: Rojanarat, Wipaporn, et al.
Publicado: (2012) -
Fabrication, in vitro and ex vivo evaluation of proliposomes and liposomal derived gel for enhanced solubility and permeability of diacerein
por: Shah, Hassan, et al.
Publicado: (2021) -
Aliskiren Hemifumarate Proliposomes for Improved Oral Drug Delivery: Formulation Development, In Vitro and In Vivo Permeability Testing
por: Kunamaneni, Priyanka, et al.
Publicado: (2022)